Synplogen Co.
Latest round
- Series C
Last raised
- Dec 2022
Total raised
- $13M
Investors
- 4
About Synplogen Co.
, Ltd., Ltd. is a biotechnology company that focuses on advanced DNA synthesis technologies., Ltd. specializes in advanced DNA synthesis technologies, primarily focusing on the OGAB® method and the Combinatorial-OGAB™ (Combi-OGAB®) technique. These methodologies enable the precise synthesis of long-chain DNA sequences, ranging from several kilobases to over 100 kilobases, with a high success rate. The company offers services for artificial gene synthesis and DNA library construction, catering specifically to the growing gene therapy market. Their products include viral vectors for gene therapy applications, designed, developed, and analyzed through their Biofoundry™ services.6 in 2022. The company's revenue model is based on B2B transactions, providing specialized DNA synthesis and gene therapy products through contract-based agreements and retainer arrangements for ongoing services. The flagship products, including those generated through the unique OGAB® technology, are priced according to the complexity and scale of the projects undertaken., Ltd. The company plans to expand its service offerings and market presence, focusing on new products related to gene therapy and DNA synthesis technologies. Targeted markets for expansion include further penetration into North America and Europe by the end of 2024. The recent capital raise will be instrumental in supporting these initiatives and enhancing the company's technological capabilities.
Who invested in Synplogen Co.
4 investors across 2 rounds
See all investors in Synplogen Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Synplogen Co.
Who invested in Synplogen Co.?
Synplogen Co. has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Synplogen Co. raised?
Synplogen Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Synplogen Co. last raise money?
Synplogen Co.'s most recent round on record is a Series C, in Dec 2022.
What does Synplogen Co. do?
Synplogen Co. is a biotechnology company.
Where is Synplogen Co. headquartered?
Synplogen Co. is headquartered in Kobe-shi, Japan.
Which VCs invest in companies like Synplogen Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Synplogen Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Synplogen Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.